Request Deal Involvement
Biocon Biologics completed the acquisition of the biosimilar assets of Viatris for $3.3bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Hogan Lovells
legal advisors
Arthur Cox
legal advisors
Saraf & Partners
financial advisors
AlixPartners
legal advisors
Cravath Swaine & Moore
financial advisors
PJT Partners
financial advisors
PricewaterhouseCoopers
financial advisors
Ernst & Young
legal advisors
Goodwin Procter
legal advisors
Shardul Amarchand Mangaldas & Co
financial advisors
Allegro Capital
legal advisors
K Law
legal advisors
Herbert Smith Freehills Kramer
or
Principals
target
VIATRIS (BIOSIMILARS ASSETS)
vendor
VIATRIS
bidder
BIOCON BIOLOGICS LTD
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite